VentureBeat

Posts Tagged ‘inv:Emergent-Growth-Fund’

splashcastlogo.jpgSplashCast, a company that creates video widgets for musicians and others to promote themselves, has raised $4 million in a first round of venture funding.

Chief executive Michael Berkley describes SplashCast’s widget as a “programmable television set” for social networks, to which clients can stream multiple channels of content (see screenshot below). The Portland, Ore.-based company has some major media players on its client list, including Sony/BMG, Universal Music and MTV. It stands out from other widget makers because of the interaction it allows with users — not only can fans submit their own videos to be broadcast on the widget’s “fan channel,” they can also chat with other fans viewing the widget across different sites. (Read our thoughts on how widgets are affecting the music industry here.)

splashdemo21.jpg

SplashCast raised the round in two stages, with the initial $2 million coming in 2007. Berkley says he plans to use the money to expand SplashCast’s eight-person staff. This is a crucial time for growth, Berkley says, because there’s a “land grab” going on in the online advertising world, as companies scramble to find new, better ways to engage potential customers, especially those between 13- and 29-years-old. (We’ve reported on big media companies, like CBS, trying to make money from the widget ad world.)

Even more than the amount of the investment, Berkley says he’s excited about lead investor and new board member Mark Bayliss, whose experience includes serving as chief financial officer for Fairfax Holdings, one of the largest media companies in Australia. Over the next six months, SplashCast will try to take advantage of Bayliss’ connections and establish alliances with large advertising companies, Berkley says.

Here’s earlier coverage of SplashCast.

Emergent Growth Fund also participated in the round.

TODAY’S HEADLINES:

aerovectrx-logo-150px.gifAerovectRx takes $1.2M, looks for $5M more for inhaled drugs – AerovectRx, a Norcross, Ga., developer of inhaled-drug delivery systems, is closing a $1.2 million seed round, VentureWire reports. Investors include Georgia Venture Partners, Emergent Growth Fund, Advanced Technology Development Center Seed Fund, and angels.

The startup is one of the latest companies to enter the perilous inhaled-drug territory, which recently claimed two high-profile inhaled-insulin products — Exubera, which Pfizer pulled from the market after dropping a huge sum on marketing, and Novo Nordisk’s AERx inhaler, which the company dropped in mid-development after Pfizer’s move. (This Bloomberg story has details.) Eli Lilly and MannKind continue to pursue inhaled insulin, and Lilly’s device is in the final stages of human testing.

AerovectRx is developing a device with a vibrating mesh intended to turn a drug preparation into an aerosol for inhalation. The company hasn’t said which drugs it aims to use with the device, although an official told VentureWire that the decision will partly depend on which corporate partners it can strike deals with. AerovectRx also plans to develop its own drugs for use with the device, and is looking into a half-dozen possibilities ranging from treatments for steroid-resistant asthma to lung cancer.

Pointe Conception, endoscopic camera maker, raises $800K – Pointe Conception, a Santa Barbara, Calif., developer of medical-camera products, has raised $800,000 of an anticipated $2 million second funding round, VentureWire reports. Individual investors, including surgeons, provided the financing. Pointe Conception makes endoscopic cameras for minimally invasive surgical procedures.

Orion Healthcare aims for $250 million life-science fund – Orion Healthcare Equity Partners, a new VC firm formed by former investors with Oxford Bioscience Partners and Atlas Venture, is looking to raise $250 million for a new life-sciences fund, VentureWire reports. The fund will be used to back European and U.S. biotechs and medical-device makers. The In Vivo blog had a detailed piece on Orion Healthcare back in mid-January; read it here.

Top Stories

Recent Comments

Powered by Disqus

Recent Guest Columnists

Job Board

Links

Venturebeat Writers

  • For advertising, contact .
  • Log in

Font Size